India's cheap weight-loss drugs could reshape global obesity fight

News • March 18, 2026 • 0 Views

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Source: http://feeds.bbci.co.uk/news/world/rss.xml - Read Original